Efficacy and Safety of Baricitinib in Patients with Active Rheumatoid Arthritis and Inadequate Response to Tumour Necrosis Factor Inhibitors

Omid Zamani; B Combe; Hans-Peter Tony; Juan Sanchez Burson; Hasan Tahir; Mikkel Østergaard; Beatrice Augendre-Ferrante; Anke Beselin; Esbjörn Larsson; Marta Casillas; Josef Smolen

doi:10.1093/rheumatology/kew144.005

Efficacy and Safety of Baricitinib in Patients with Active Rheumatoid Arthritis and Inadequate Response to Tumour Necrosis Factor Inhibitors

Omid Zamani, B Combe, Hans-Peter Tony, Juan Sanchez Burson, Hasan Tahir, Mikkel Østergaard, Beatrice Augendre-Ferrante, Anke Beselin, Esbjörn Larsson, Marta Casillas, Josef Smolen

Institut for Klinisk Medicin

Originalsprog	Engelsk
Artikelnummer	078
Tidsskrift	Rheumatology
Vol/bind	55
Udgave nummer	suppl 1
Antal sider	1
ISSN	1462-0324
DOI	https://doi.org/10.1093/rheumatology/kew144.005
Status	Udgivet - 2016

Adgang til dokumentet

10.1093/rheumatology/kew144.005

Citationsformater

Zamani, O., Combe, B., Tony, H-P., Burson, J. S., Tahir, H., Østergaard, M., Augendre-Ferrante, B., Beselin, A., Larsson, E., Casillas, M., & Smolen, J. (2016). Efficacy and Safety of Baricitinib in Patients with Active Rheumatoid Arthritis and Inadequate Response to Tumour Necrosis Factor Inhibitors. Rheumatology, 55(suppl 1), [078]. https://doi.org/10.1093/rheumatology/kew144.005

Zamani, O, Combe, B, Tony, H-P, Burson, JS, Tahir, H, Østergaard, M, Augendre-Ferrante, B, Beselin, A, Larsson, E, Casillas, M & Smolen, J 2016, 'Efficacy and Safety of Baricitinib in Patients with Active Rheumatoid Arthritis and Inadequate Response to Tumour Necrosis Factor Inhibitors', Rheumatology, bind 55, nr. suppl 1, 078. https://doi.org/10.1093/rheumatology/kew144.005

@article{6d48f28ad19749e88cf48b2a2e746749,

title = "Efficacy and Safety of Baricitinib in Patients with Active Rheumatoid Arthritis and Inadequate Response to Tumour Necrosis Factor Inhibitors",

author = "Omid Zamani and B Combe and Hans-Peter Tony and Burson, {Juan Sanchez} and Hasan Tahir and Mikkel {\O}stergaard and Beatrice Augendre-Ferrante and Anke Beselin and Esbj{\"o}rn Larsson and Marta Casillas and Josef Smolen",

year = "2016",

doi = "10.1093/rheumatology/kew144.005",

language = "English",

volume = "55",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "suppl 1",

}

TY - ABST

T1 - Efficacy and Safety of Baricitinib in Patients with Active Rheumatoid Arthritis and Inadequate Response to Tumour Necrosis Factor Inhibitors

AU - Zamani, Omid

AU - Combe, B

AU - Tony, Hans-Peter

AU - Burson, Juan Sanchez

AU - Tahir, Hasan

AU - Østergaard, Mikkel

AU - Augendre-Ferrante, Beatrice

AU - Beselin, Anke

AU - Larsson, Esbjörn

AU - Casillas, Marta

AU - Smolen, Josef

PY - 2016

Y1 - 2016

U2 - 10.1093/rheumatology/kew144.005

DO - 10.1093/rheumatology/kew144.005

M3 - Conference abstract in journal

SN - 1462-0324

VL - 55

JO - Rheumatology

JF - Rheumatology

IS - suppl 1

M1 - 078

ER -